AMEX · Healthcare · Drug Manufacturers - Specialty & Generic · China
China Pharma Holdings Inc is a micro cap company (market value under $300 million) in the Drug Manufacturers - Specialty & Generic industry.
China Pharma Holdings Inc operates through its Chinese subsidiary Helpson to develop and produce pharmaceutical medications treating various prevalent diseases in China. The company manufactures injectable formulations, oral tablets and capsule products, with manufacturing facilities located in Haikou. Its product range encompasses basic generics, newly available generic drugs and modern Traditional Chinese Medicines distributed to hospitals and pharmacies.
From its FY2025 annual report (Form 10-K)
Intrinsic value, DCF valuation, financial health and value investing analysis for the China Pharma Holdings Inc stock.
Not valued: We cannot value this company yet.
We do not publish a value for this company: not even its current assets cover what it owes.
All 84 Drug Manufacturers - Specialty & Generic stocks
35 more in this industry show a wider margin of safety.
We do not publish a verdict on CPHI yet. We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.
We do not publish one (as of the 2026-10-30 close). We are missing a figure this valuation depends on. We would rather say so than show a number built on a guess.